|
1
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Aravalli RN, Steer CJ and Cressman EN:
Molecular mechanisms of hepatocellular carcinoma. Hepatology.
48:2047–2063. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Llovet JM, Burroughs A and Bruix J:
Hepatocellular carcinoma. Lancet. 362:1907–1917. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Shaw JJ and Shah SA: Rising incidence and
demographics of hepatocellular carcinoma in the USA: What does it
mean? Expert Rev Gastroenterol Hepatol. 5:365–370. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Taylor-Robinson SD, Toledano MB, Arora S,
Keegan TJ, Hargreaves S, Beck A, Khan SA, Elliott P and Thomas HC:
Increase in mortality rates from intrahepatic cholangiocarcinoma in
England and Wales 1968–1998. Gut. 48:816–820. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Calin GA and Croce CM: MicroRNA signatures
in human cancers. Nat Rev Cancer. 6:857–866. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Esquela-Kerscher A and Slack FJ: Oncomirs
- microRNAs with a role in cancer. Nat Rev Cancer. 6:259–269. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kosaka N, Iguchi H, Hagiwara K, Yoshioka
Y, Takeshita F and Ochiya T: Neutral sphingomyelinase 2
(nSMase2)-dependent exosomal transfer of angiogenic microRNAs
regulate cancer cell metastasis. J Biol Chem. 288:10849–10859.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Allen KE and Weiss GJ: Resistance may not
be futile: microRNA biomarkers for chemoresistance and potential
therapeutics. Mol Cancer Ther. 9:3126–3136. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ma J, Dong C and Ji C: MicroRNA and drug
resistance. Cancer Gene Ther. 17:523–531. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Sarkar FH, Li Y, Wang Z, Kong D and Ali S:
Implication of microRNAs in drug resistance for designing novel
cancer therapy. Drug Resist Updat. 13:57–66. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zheng T, Wang J, Chen X and Liu L: Role of
microRNA in anticancer drug resistance. Int J Cancer. 126:2–10.
2010. View Article : Google Scholar
|
|
14
|
Song B, Wang Y, Titmus MA, Botchkina G,
Formentini A, Kornmann M and Ju J: Molecular mechanism of
chemoresistance by miR-215 in osteosarcoma and colon cancer cells.
Mol Cancer. 9:96–105. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Karaayvaz M, Pal T, Song B, Zhang C,
Georgakopoulos P, Mehmood S, Burke S, Shroyer K and Ju J:
Prognostic significance of miR-215 in colon cancer. Clin Colorectal
Cancer. 10:340–347. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
White NM, Khella HW, Grigull J, Adzovic S,
Youssef YM, Honey RJ, Stewart R, Pace KT, Bjarnason GA, Jewett MA,
et al: miRNA profiling in metastatic renal cell carcinoma reveals a
tumour-suppressor effect for miR-215. Br J Cancer. 105:1741–1749.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ivan C, Hu W, Bottsford-Miller J, et al:
Comprehensive epigenetic analysis of Notch pathway in high-grade
serous ovarian cancer. Gynecol Oncol. 128:506–511. 2013. View Article : Google Scholar :
|
|
18
|
Mu J, Pang Q, Guo YH, Chen JG, Zeng W,
Huang YJ, Zhang J and Feng B: Functional implications of
microRNA-215 in TGF-β1-induced phenotypic transition of mesangial
cells by targeting CTNNBIP1. PLoS One. 8:e586222013. View Article : Google Scholar
|
|
19
|
Chen C, Ridzon DA, Broomer AJ, Zhou Z, Lee
DH, Nguyen JT, Barbisin M, Xu NL, Mahuvakar VR, Andersen MR, et al:
Real-time quantification of microRNAs by stem-loop RT-PCR. Nucleic
Acids Res. 33:e1792005. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Ou YC, Yang CR, Cheng CL, Raung SL, Hung
YY and Chen CJ: Indomethacin induces apoptosis in 786-O renal cell
carcinoma cells by activating mitogen-activated protein kinasesand
AKT. Eur J Pharmacol. 563:49–60. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Chehrehasa F, Meedeniya AC, Dwyer P,
Abrahamsen G and Mackay-Sim A: EdU, a new thymidine analogue for
labelling proliferating cells in the nervous system. J Neurosci
Methods. 177:122–130. 2009. View Article : Google Scholar
|
|
22
|
Wu QP, Xie YZ, Deng Z, Li XM, Yang W, Jiao
CW, Fang L, Li SZ, Pan HH, Yee AJ, Lee DY, Li C, Zhang Z, Guo J and
Yang BB: Ergosterol peroxide isolated from Ganoderma lucidum
abolishes microRNA miR-378-mediated tumor cells onchemoresistance.
PLoS One. 7:e445792012. View Article : Google Scholar
|
|
23
|
Park YT, Jeong JY, Lee MJ, Kim KI, Kim TH,
Kwon YD, Lee C, Kim OJ and An HJ: MicroRNAs overexpressed in
ovarian ALDH1-positive cells are associated with chemoresistance. J
Ovarian Res. 6:182013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Robin TP, Smith A, McKinsey E, Reaves L,
Jedlicka P and Ford HL: EWS/FLI1 regulates EYA3 in Ewing sarcoma
via modulation of miRNA-708, resulting in increased cell survival
and chemoresistance. Mol Cancer Res. 10:1098–1108. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Fujita Y, Kojima K, Hamada N, Ohhashi R,
Akao Y, Nozawa Y, Deguchi T and Ito M: Effects of miR-34a on cell
growth and chemo-resistance in prostate cancer PC3 cells. Biochem
Biophys Res Commun. 377:114–119. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Huang JY, Cui SY, Chen YT, Song HZ, Huang
GC, Feng B, Sun M, De W, Wang R and Chen LB: MicroRNA-650 was a
prognostic factor in human lung adenocarcinoma and confers the
docetaxel chemoresistanceof lung adenocarcinoma cells via
regulating Bcl-2/Bax expression. PLoS One. 8:e726152013. View Article : Google Scholar
|
